Literature DB >> 27503502

Importance of environmental stiffness for megakaryocyte differentiation and proplatelet formation.

Alicia Aguilar1,2,3,4, Fabien Pertuy1,2,3,4, Anita Eckly1,2,3,4, Catherine Strassel1,2,3,4, Dominique Collin5, Christian Gachet1,2,3,4, François Lanza1,2,3,4, Catherine Léon1,2,3,4.   

Abstract

Megakaryocyte (MK) differentiation occurs within the bone marrow (BM), a complex 3-dimensional (3D) environment of low stiffness exerting local external constraints. To evaluate the influence of the 3D mechanical constraints that MKs may encounter in vivo, we differentiated mouse BM progenitors in methylcellulose (MC) hydrogels tuned to mimic BM stiffness. We found that MKs grown in a medium of 30- to 60-Pa stiffness more closely resembled those in the BM in terms of demarcation membrane system (DMS) morphological aspect and exhibited higher ploidy levels, as compared with MKs in liquid culture. Following resuspension in a liquid medium, MC-grown MKs displayed twice as much proplatelet formation as cells grown in liquid culture. Thus, the MC gel, by mimicking external constraints, appeared to positively influence MK differentiation. To determine whether MKs adapt to extracellular stiffness through mechanotransduction involving actomyosin-based modulation of the intracellular tension, myosin-deficient (Myh9-/-) progenitors were grown in MC gels. Absence of myosin resulted in abnormal cell deformation and strongly decreased proplatelet formation, similarly to features observed for Myh9-/- MKs differentiated in situ but not in vitro. Moreover, megakaryoblastic leukemia 1 (MKL1), a well-known actor in mechanotransduction, was found to be preferentially relocated within the nucleus of MC-differentiated MKs, whereas its inhibition prevented MC-mediated increased proplatelet formation. Altogether, these data show that a 3D medium mimicking BM stiffness contributes, through the myosin IIA and MKL1 pathways, to a more favorable in vitro environment for MK differentiation, which ultimately translates into increased proplatelet production.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27503502     DOI: 10.1182/blood-2016-02-699959

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Tense your megas! Structural rigidity is key.

Authors:  Bethan Psaila
Journal:  Blood       Date:  2016-10-20       Impact factor: 22.113

2.  Multi-channel silk sponge mimicking bone marrow vascular niche for platelet production.

Authors:  Lorenzo Tozzi; Pierre-Alexandre Laurent; Christian A Di Buduo; Xuan Mu; Angelo Massaro; Ross Bretherton; Whitney Stoppel; David L Kaplan; Alessandra Balduini
Journal:  Biomaterials       Date:  2018-06-17       Impact factor: 12.479

Review 3.  In vitro generation of platelets: Where do we stand?

Authors:  C A Di Buduo; D L Kaplan; A Balduini
Journal:  Transfus Clin Biol       Date:  2017-06-29       Impact factor: 1.406

Review 4.  New Insights Into the Differentiation of Megakaryocytes From Hematopoietic Progenitors.

Authors:  Leila J Noetzli; Shauna L French; Kellie R Machlus
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-05-02       Impact factor: 8.311

5.  Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease.

Authors:  Kasturi Pal; Roberta Nowak; Neil Billington; Rong Liu; Arit Ghosh; James R Sellers; Velia M Fowler
Journal:  Blood       Date:  2020-05-21       Impact factor: 22.113

Review 6.  Mechanical forces direct stem cell behaviour in development and regeneration.

Authors:  Kyle H Vining; David J Mooney
Journal:  Nat Rev Mol Cell Biol       Date:  2017-11-08       Impact factor: 94.444

Review 7.  The role of extracellular matrix stiffness in megakaryocyte and platelet development and function.

Authors:  Orly Leiva; Catherine Leon; Seng Kah Ng; Pierre Mangin; Christian Gachet; Katya Ravid
Journal:  Am J Hematol       Date:  2018-01-12       Impact factor: 10.047

8.  Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors.

Authors:  Amanda L Evans; Amanda Dalby; Holly R Foster; Daniel Howard; Amie K Waller; Momal Taimoor; Moyra Lawrence; Souradip Mookerjee; Marcus Lehmann; Annie Burton; Jorge Valdez; Jonathan Thon; Joseph Italiano; Thomas Moreau; Cedric Ghevaert
Journal:  Blood Adv       Date:  2021-04-13

9.  Fetal vs adult megakaryopoiesis.

Authors:  Patricia Davenport; Zhi-Jian Liu; Martha Sola-Visner
Journal:  Blood       Date:  2022-06-02       Impact factor: 25.476

10.  A new path to platelet production through matrix sensing.

Authors:  Vittorio Abbonante; Christian Andrea Di Buduo; Cristian Gruppi; Carmelo De Maria; Elise Spedden; Aurora De Acutis; Cristian Staii; Mario Raspanti; Giovanni Vozzi; David L Kaplan; Francesco Moccia; Katya Ravid; Alessandra Balduini
Journal:  Haematologica       Date:  2017-04-14       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.